1022. Clinical and Economic Impact of the Implementation of an Antibiotic Flowchart for Complicated Urinary Tract Infection in a Tertiary Care Hospital in Colombia
Session: Poster Abstract Session: Antibiotic Stewardship: General Acute Care Implementation and Outcomes
Friday, October 28, 2016
Room: Poster Hall
  • Poster Flujogramas final.pdf (491.7 kB)
  • Background: Complicated urinary tract infection (cUTI) is one of the most common diagnoses in the emergency department (ED) and a major cause of mortality. A prompt and appropriate empiric antibiotic therapy prevents complications and reduces the length of stay, healthcare costs and mortality. The aim of this study was to determine the clinical and economic impact of the implementation in the ED of an antibiotic flowchart for cUTI.

    Methods: Adult patients admitted to the ED of a tertiary care hospital in Colombia, between January and April 2016, treated with empiric antibiotics for cUTI were included and followed until completion of their antibiotic regimen. An antibiotic flowchart which considered risk factors for multidrug-resistant bacteria and patient stratification by severity was implemented to guide cUTI treatment. Patients who were treated empirically following the flowchart were considered the adherent group, and those not treated according to the flowchart were the non-adherent group. Clinical and economic outcomes were compared between groups. Data was analyzed using descriptive and inferential statistics.

    Results: A total of 50 patients with cUTI were included; 39 (78%) were adherent and 11 (22%) were non-adherent. The mean age was 66 years old; 29 (58%) women and 21 (42%) men. Escherichia coli was the most common bacteria isolated (72%). Complications occurred more frequently in the non-adherent group (45% vs. 13%, p = 0.01). After 48 hours of antibiotic therapy, 78% of adherent patients improved their symptoms in contrast to 9% of non-adherent patients and at the end of treatment, the symptom’s resolution was more frequent in the adherent group (78% vs. 36%, p = 0.006). The mortality rate was also higher in the non-adherent group (20% vs. 2.5%, p = 0.06). Regarding clinical tests, the mean cost per patient in the non-adherent group was $282 USD vs. $113 USD in the adherent group (p = 0.01).

    Conclusion: Our findings demonstrate that clinical and economic outcomes are significantly better for patients in the ED treated for cUTI according to an antibiotic flowchart. Flowcharts for other common infections should be implemented and measured as it seems to be a very efficient way to implement prompt and appropriate empiric antibiotic therapy in the ED.

    Sergio Reyes, MD1, Christian Pallares, MD, MSc1, Cristhian Hernández-Gómez, BSc1, Kevin Escandón-Vargas, MD1, David Aragon, MD2 and Maria Virginia Villegas, MD, MSc, FIDSA1, (1)Bacterial Resistance and Hospital Epidemiology, International Center for Medical Research and Training CIDEIM, Cali, Colombia, (2)Centro Médico Imbanaco, Cali, Colombia


    S. Reyes, None

    C. Pallares, Merck Sharp & Dohme: Consultant , Consulting fee

    C. Hernández-Gómez, Merck Sharp & Dohme: Consultant , Consulting fee

    K. Escandón-Vargas, None

    D. Aragon, None

    M. V. Villegas, Merck Sharp & Dohme: Consultant , Consulting fee and Research support

    Findings in the abstracts are embargoed until 12:01 a.m. CDT, Wednesday Oct. 26th with the exception of research findings presented at the IDWeek press conferences.